Organized by: JETRO Osaka, JETRO Kyoto, Kyoto City, Astem (Advanced Scientific Technology & Management Research Institute of Kyoto)
As a side event to “IVS Kyoto,” one of Japan’s largest startup conferences, we are hosting a global matching event for the life sciences sector in Kyoto!
At this event, eight cutting-edge life sciences startups from overseas—invited to Japan by JETRO Osaka—will take the stage. In addition to each company’s innovative business pitch, we’ll feature a panel discussion exploring the current state and appeal of Kyoto City’s ever-evolving “Life Sciences Ecosystem.”
Following the pitches, we’ve set aside time for networking, where presenting companies, ecosystem stakeholders, and all participants can connect deeply across borders.
We warmly welcome companies seeking to collaborate with overseas startups, investors and researchers eager to engage with the latest technologies, and anyone who wants to help shape the future of life sciences together.
Event Overview
Date & Time: Friday, July 3, 2026, 18:00–20:30
Venue: Kyoto Economic Center, 6th Floor, Conference Room 6D
Organizers / Co-organizers: JETRO Osaka, JETRO Kyoto, Kyoto City, Astem (Advanced Scientific Technology & Management Research Institute of Kyoto)
Support: Osaka Prefecture (TBC)
Admission: Free
Capacity: 80 people (first-come-first-served basis)
Time Table
18:00 Opening
18:05 About the Kyoto City Life Sciences Ecosystem
18:15 Overseas Startup Presentations (4 companies)
18:35 Panel Discussion
18:50 Overseas Startup Presentations (4 companies)
19:10 Networking (light refreshments & drinks) @Conference Room 6C
20:30 Closing
★ Content is subject to change.
★ Japanese cuisine will be served during the networking session.
Featured Startups
① CanSense (UK)
A UK-based biomedical startup aiming for the early detection of colorectal cancer through a blood test powered by AI and spectroscopy.
② CellProthera (France)
A biotechnology company developing stem cell–based regenerative medicine for purposes such as regenerating cardiac tissue after myocardial infarction.
③ Myomar Molecular (Canada)
A healthtech company developing biomarker diagnostic technology (notably a urine test) to detect and monitor muscle health and early signs of muscle atrophy.
④ NETRI (France)
A biotech company that predicts the efficacy and safety of drugs using “organs-on-chip” technology combining neurons with AI.
⑤ REVEAL GENOMICS (Spain)
A biotechnology company developing genomic diagnostic technology to provide optimal treatment options for cancer patients, starting with breast cancer.
⑥ SwiftPharma (Belgium)
A biotech company that uses plants as bioreactors to produce non-animal-derived pharmaceutical proteins—such as vaccines and antibodies—in a low-cost, sustainable way.
⑦ Viamab Therapeutics (UK)
Developing the world’s first RAGE-targeting antibody-drug conjugate (ADC), focused primarily on metastatic colorectal cancer, with clinical trials set to begin soon.
⑧ ZILIA (Canada)
A medical technology company that uses spectroscopy and AI to non-invasively measure biomarkers such as intraocular oxygen saturation, aiming for the early diagnosis of ocular and systemic diseases.
※ For detailed materials and pitch decks on each startup, please see the link below:
https://www5.jetro.go.jp/newsletter/osd/2026/20260526_HealthX_Connect_Osaka.pdf
※ Your personal information will be properly managed in accordance with JETRO’s privacy policy. For more details, please refer to “Protection of Personal Information.”